CardioGenics Holdings Inc
CGNH
Rank in Stocks
#34379
CardioGenics Holdings Inc. focuses on the creation and global distribution of... CardioGenics Holdings Inc. focuses on the creation and global distribution of diagnostic testing solutions within the in vitro diagnostics (IVD) sector, serving markets across the United States, Canada, Europe, and other international regions. A key offering is the QL Care Analyzer, an automated, self-contained, and portable point-of-care (POC) immunoassay device. This analyzer utilizes a unique, patented self-metering cartridge to perform immunoassay evaluations directly at the point of care. The company also provides a range of immunoassay panels specifically engineered to detect cardiac biomarkers in blood, which is vital for identifying heart attacks. Additionally, CardioGenics supplies paramagnetic beads, serving as crucial solid supports in heterogeneous immunoassay procedures for both clinical and research institutions. Established in 1997, the company was initially known as Jag Media Holdings, Inc. before officially changing its name to CardioGenics Holdings Inc. in 2009. Its corporate headquarters are situated in Mississauga, Canada.
Share Price
$0.0001
Last synced: 2026-11-19
Market Cap
$11.67K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade CardioGenics Holdings Inc (CGNH)
Category
Healthcare
Operating Margin for CardioGenics Holdings Inc (CGNH)
Operating Margin as of November 2026 TTM: 0.00%
According to CardioGenics Holdings Inc's latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2015 the company had an operating margin of 0.00%.
Operating Margin history for CardioGenics Holdings Inc from 2000 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2015 | 0.00% | 0.00% |
| 2014 | 0.00% | 0.00% |
| 2013 | 0.00% | -100.00% |
| 2012 | -101,288.28% | 137.28% |
| 2011 | -42,686.83% | 0.00% |
| 2010 | 0.00% | -100.00% |
| 2009 | -74,836.85% | 7,367.63% |
| 2008 | -1,002.15% | 18.38% |
| 2007 | -846.53% | -39.88% |
| 2006 | -1,408.18% | 98.32% |
| 2005 | -710.04% | -9.39% |
| 2004 | -783.59% | 19.05% |
| 2003 | -658.21% | 2.35% |
| 2002 | -643.10% | -56.63% |
| 2001 | -1,482.69% | 3.58% |
| 2000 | -1,431.51% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 17.98% | - |
US
|
|
| 20.38% | - |
US
|
|
| 43.02% | - |
CN
|
|
| 32.30% | - |
US
|
|
| 22.23% | - |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about CardioGenics Holdings Inc's operating margin
What was CardioGenics Holdings Inc's operating margin in 2015?
In 2015, CardioGenics Holdings Inc's operating margin was 0.00%, compared with 0.00% in 2014.
How has CardioGenics Holdings Inc's operating margin changed since 2010?
From 2010 to 2015, CardioGenics Holdings Inc's operating margin was highest in 2015 (0.00%) and lowest in 2012 (-101,288.28%).
How does CardioGenics Holdings Inc's operating margin compare with similar companies?
CardioGenics Holdings Inc's operating margin (0.00%) is lower than that of all 5 similar companies listed above. The highest among them is WuXi AppTec Co., Ltd., with 43.02%.